Molecular-genetic risk assessement of determining angiotensin-converting enzyme hyperactivity in hemorrhagic fever with renal syndrome
Russian Open Medical Journal · 2012
DOI: 10.15275/rusomj.2012.0201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Russian Open Medical Journal, 2012. Verfasst von Asiya A. Baygildina und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Baygildina, A. A., Islamgulov, D. V., Kamilov, F. K., Khabelova, T. A., & Minniakhmetov, I. R. (2012). Molecular-genetic risk assessement of determining angiotensin-converting enzyme hyperactivity in hemorrhagic fever with renal syndrome. Russian Open Medical Journal. https://doi.org/10.15275/rusomj.2012.0201
Vancouver
Baygildina AA, Islamgulov DV, Kamilov FK, Khabelova TA, Minniakhmetov IR. Molecular-genetic risk assessement of determining angiotensin-converting enzyme hyperactivity in hemorrhagic fever with renal syndrome. Russian Open Medical Journal. 2012. doi:10.15275/rusomj.2012.0201
BibTeX
@article{Baygildina2012,
author = {Baygildina, Asiya A. and Islamgulov, Denis V. and Kamilov, Felix Kh. and Khabelova, Tamara A. and Minniakhmetov, Ildar R.},
title = {Molecular-genetic risk assessement of determining angiotensin-converting enzyme hyperactivity in hemorrhagic fever with renal syndrome},
journal = {Russian Open Medical Journal},
year = {2012},
doi = {10.15275/rusomj.2012.0201}
}
EUVIMED